If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
816.00    6.00 (0.74%)
Bid:
808.00
Ask:
818.00
Spread: 10.00 (1.238%)
Market Cap: £376.14m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

AGM Trading Update

14 Apr 2026 07:00

RNS Number : 2840A
Porvair PLC
14 April 2026
 

14 April 2026

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

AGM Trading Update

Group trading remains in line with our full year expectations. Integration of Drache acquisition remains on track.

Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory and environmental technology group, will make the following trading statement at its Annual General Meeting to be held at 11.00 am today:

Four-month trading summary for the period to 31 March 2026

The Group has performed in line with expectations in the first four months of the year, delivering constant currency revenue growth of 5%. This performance reflects the qualities of Porvair's diversified portfolio, as market conditions remain varied across the Group's end markets.

Aerospace & Industrial

Aerospace order books remain strong, noting that the timing of delivery can be affected by changes in customer scheduling. Robust nuclear demand in the second half of 2025 has continued into the current year. Petrochemical sales, which can be lumpy, are lower compared with a strong prior period, and conditions in the European petrochemical market are expected to remain subdued throughout 2026.

Laboratory

Within life sciences, consumables order patterns remain steady, while environmental demand for instruments is in line with the prior year. New product introductions across life sciences and environmental are progressing as planned.

Metal Melt Quality

Aluminium and superalloys demand remains firm, whilst the auto, truck and agriculture end-markets, which represent a smaller part of the Group, remain subdued. There has been good progress with the new £5.5m aluminium cast house manufacturing line in Hendersonville, US, which remains on track for commissioning in the first half of 2026. The integration of Drache, acquired on 12 January 2026, is progressing well after three months with the Group and trading is consistent with the pre-acquisition investment case.

Outlook

The Board is closely monitoring the situation in the Middle East, in terms of both macro uncertainty and rising input prices. The Group's manufacturing footprint mainly serves local customers, and its decentralised management structure provides flexibility, agility and resilience in navigating volatile trading conditions, enabling key commercial decisions to be made closer to customers and suppliers.

The Board's expectations of the Group's full year performance remain unchanged, supported by a diversified customer base, strong recurring revenue streams and disciplined operational management. An increased focus on identifying M&A targets has surfaced some interesting prospects which are currently being evaluated. The Board sees no change in the Group's long-term strategic outlook or global growth drivers.

Capital Markets Event

Further to the full year results announcement, Porvair will host a Capital Markets Event in London on Thursday, 15 October 2026. Further details will be provided in due course.

Notice of results

The Group will announce its interim results for the six months ending 31 May 2026 on Monday 29 June 2026.

 

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

James Mills, Group Finance Director

 

Alma Strategic Communications

+44 (0)20 3405 0205

Andrew Jaques / Josh Royston / Hannah Campbell / Rose Docherty

 

 

LEI: 213800ECKHS8LAQO3C45

 

Notes to editors

Porvair is a group of specialist filtration, laboratory and environmental technology companies. Our businesses design and manufacture bespoke consumable filtration products that are used in a range of niche markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMEAFLDFASKEAA
Date   Source Headline
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.